material omissions

SES AI investors with $100K+ losses have until June 26, 2026 to apply as lead plaintiff in securities lawsuit alleging material misstatements.

Law firm Kahn Swick & Foti announces class action against Gemini Space Station, alleging false IPO statements. Investors have until May 18, 2026 to join.

Soleno Therapeutics faces securities fraud lawsuit alleging undisclosed DCCR safety risks. Investors must file by May 5, 2026.

Law firm files class action against Gemini Space Station for allegedly overstating crypto platform viability and financial prospects in IPO disclosures.

Kahn Swick & Foti sues Navan for allegedly concealing 39% spike in sales/marketing expenses to $95M in Q3 2025 during October IPO. Deadline April 24, 2026.

Investors in $DOOR must act by April 7, 2026 to join class action alleging material omissions regarding Owens Corning acquisition and share repurchases.

Law firm alleges Navan concealed 39% surge in sales-marketing spending to $95M in Q3 2025 during October IPO. Class action deadline set for April 24, 2026.

Rosen Law Firm urges Masonite investors with $100K+ losses to seek counsel before April 2026 lead plaintiff deadline in securities class action.

Securities lawsuit alleges $SLNO concealed safety concerns about DCCR, its only commercial product for Prader-Willi syndrome treatment, ahead of May 5, 2026 lead plaintiff deadline.

Gemini Space Station shareholders with $100K+ losses must file lead plaintiff applications by May 18, 2026 in class action suit alleging material disclosure failures.

Soleno Therapeutics faces securities lawsuit alleging undisclosed safety risks in its sole commercial product DCCR. Investors have until May 5, 2026 to seek lead plaintiff status.

Rosen Law Firm alerts $DOOR investors to April 7, 2026 deadline in securities suit alleging material omissions regarding Owens Corning acquisition offers.

Law firm Kahn Swick & Foti alleges Soleno Therapeutics failed to disclose material safety concerns with its flagship DCCR product, with lead plaintiff applications due May 5, 2026.

Navan faces class action lawsuit alleging failure to disclose 39% surge in marketing costs to $95M in Q3 2025 during October IPO, with lead plaintiff applications due April 24, 2026.

Rosen Law Firm urges Masonite investors to join class action lawsuit alleging material omissions regarding Owens Corning acquisition and share repurchases.

Enphase Energy faces class action lawsuit over alleged material misstatements regarding inventory management and tax credit impacts. Lead plaintiff deadline set for April 20, 2026.

Soleno Therapeutics faces class action lawsuit alleging material safety concerns about DCCR drug were hidden from investors. Lead plaintiff deadline is May 5, 2026.

Apollo Global Management faces securities fraud lawsuit over alleged undisclosed Epstein communications involving executives Rowan and Black. Stock fell 16% during disputed period.

Navan faces class action lawsuit alleging material IPO disclosure gaps regarding $95M sales-marketing expenses. April 24, 2026 deadline for lead plaintiff applications.

Class action lawsuit filed against Soleno Therapeutics for allegedly failing to disclose material safety concerns about its DCCR product. Investors can apply as lead plaintiff by May 5, 2026.